AlphaStocks
5.3
Consider Buy

Zoetis Inc. (ZTS)

Health Care / Pharmaceuticals

S&P 500

$117.31

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

#481out of 1127 in Health Care

Is Zoetis Inc. a Good Investment in 2026?

Zoetis Inc. (ZTS) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Zoetis Inc. as Strong (8/9). The Graham model is the least favorable, rating it Neutral. Zoetis Inc. currently trades below its estimated fair value of $163, suggesting potential upside. Zoetis Inc. ranks #481 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E19.5ROE61.2Market Cap52BDiv Yield1.7

Estimated Fair Value

$163.1728% below

Fair value above market price. ROE of 61% signals strong profitability. P/E of 19x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Attractive

PEG 1.0 · Fast Grower

Greenblatt

Strong

Top 25% (rank 14%)

Frequently Asked Questions

Is Zoetis Inc. (ZTS) a good investment?
Based on AlphaStocks' composite analysis, Zoetis Inc. (ZTS) scores 5.3 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Fair value above market price. ROE of 61% signals strong profitability. P/E of 19x is moderate for this quality level.
What is Zoetis Inc.'s Piotroski F-Score?
Zoetis Inc.'s Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ZTS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $163, ZTS appears undervalued. The stock currently trades 28% below its estimated fair value. Fair value above market price. ROE of 61% signals strong profitability. P/E of 19x is moderate for this quality level.
How does ZTS compare to other Health Care stocks?
Zoetis Inc. ranks #481 out of 1127 stocks in the Health Care sector, placing it in the top 43% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about ZTS?
AlphaStocks evaluates ZTS using five proven investment models. Piotroski: Strong; Buffett: Strong; Graham: Neutral; Lynch: Attractive; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.3/10.

Similar Stocks

PARRFTIAZN

Compare ZTS with

ZTS vs PARRZTS vs FTIZTS vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer